Eli Lilly Director Gabrielle Sulzberger Receives Stock Units in Lieu of Cash Retainer

Executive Summary

On October 20, 2026, Eli Lilly and Company ($LLY) reported a Form 4 transaction for Director Gabrielle Sulzberger. On October 19, 2026, Sulzberger acquired 3.9976 shares of Common Stock at a price of $1,240.34 per share, representing an aggregate transaction value of approximately $4,958.38.

Transaction Details

• Security: Common Stock
• Nature of Transaction: Code 'A' (Grant/Award).
• Footnote Context: As noted in Footnote 1, the shares were deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan. They will be settled in common stock upon separation from service.
• Direct Ownership Post-Transaction: 3,016.4449 shares.

Market and Trading Impact

• Significance: Low.
• Rationale: This is an automatic, routine compensation election under the company's director deferral program and does not represent open-market discretionary buying or selling. The minimal transaction size (~$4.96K) has virtually no implications for broader investor sentiment or stock trajectory.